A detailed history of Money Concepts Capital Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, Money Concepts Capital Corp holds 10,997 shares of NVO stock, worth $960,807. This represents 0.1% of its overall portfolio holdings.

Number of Shares
10,997
Previous 10,524 4.49%
Holding current value
$960,807
Previous $1.5 Million 12.85%
% of portfolio
0.1%
Previous 0.13%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 31, 2024

BUY
$119.07 - $145.42 $56,320 - $68,783
473 Added 4.49%
10,997 $1.31 Million
Q2 2024

Aug 02, 2024

SELL
$122.71 - $146.91 $29,204 - $34,964
-238 Reduced 2.21%
10,524 $1.5 Million
Q1 2024

May 01, 2024

BUY
$102.11 - $135.92 $269,774 - $359,100
2,642 Added 32.54%
10,762 $1.38 Million
Q4 2023

Feb 12, 2024

SELL
$87.78 - $105.45 $9,216 - $11,072
-105 Reduced 1.28%
8,120 $840,000
Q3 2023

Oct 31, 2023

BUY
$90.94 - $199.54 $405,046 - $888,751
4,454 Added 118.11%
8,225 $747,000
Q2 2023

Jul 31, 2023

SELL
$155.98 - $172.65 $130,399 - $144,335
-836 Reduced 18.15%
3,771 $610,000
Q1 2023

May 01, 2023

SELL
$132.34 - $159.14 $147,294 - $177,122
-1,113 Reduced 19.46%
4,607 $733,000
Q4 2022

Feb 14, 2023

BUY
$102.55 - $135.33 $303,445 - $400,441
2,959 Added 107.17%
5,720 $774,000
Q3 2022

Oct 27, 2022

BUY
$95.28 - $116.93 $95,565 - $117,280
1,003 Added 57.05%
2,761 $275,000
Q2 2022

Jul 18, 2022

SELL
$103.24 - $121.81 $156,098 - $184,176
-1,512 Reduced 46.24%
1,758 $196,000
Q1 2022

May 13, 2022

BUY
$93.1 - $112.54 $120,192 - $145,289
1,291 Added 65.23%
3,270 $363,000
Q4 2021

Feb 14, 2022

BUY
$95.88 - $117.08 $189,746 - $231,701
1,979 New
1,979 $222,000
Q1 2021

May 17, 2021

SELL
$67.06 - $75.82 $206,276 - $233,222
-3,076 Closed
0 $0
Q4 2020

May 17, 2021

BUY
$63.89 - $73.8 $196,525 - $227,008
3,076 New
3,076 $215,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Money Concepts Capital Corp Portfolio

Follow Money Concepts Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Money Concepts Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Money Concepts Capital Corp with notifications on news.